2024-11-20 16:40:19
APRINOIA Therapeutics received FDA clearance to initiate APNmAb005 Phase 1 clinical trial
Health/ 2023-07-22
APRINOIA Therapeutics received FDA clear...

BOSTON,April 11,2022-- APRINOIA Therapeutics announces today that the U.S. Food and Drug Administration (FDA) has granted a may proceed auth...

InventisBio Reported Promising Phase I Study Results of a Novel KRAS G12C Inhibitor D-1553 in Cancer Patients
Health/ 2023-07-22
InventisBio Reported Promising Phase I S...

SHANGHAI,April 11,2022--InventisBio Co.,Ltd.,a clinical-stage biotech company based in Shanghai,China has published the clinical data of the...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release